News

Article

Pharmaceutical Technology

Pharmaceutical Technology-02-02-2002
Volume26
Issue 2

Microbial Bioburden on Oral Solid Dosage Forms

Author(s):

José E. Martinez

Low levels of some microorganisms that are present in oral solid dosage forms are unlikely to present a risk to patients. The amount of water activity in these products can help determine when microbiological testing should be conducted.

External Link - article-9672.pdf

Articles in this issue
Using Earned-Value Analysis to Better Manage Projects
Microbial Bioburden on Oral Solid Dosage Forms
Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part I
Modernizing Pharmaceutical Manufacturing
The Role of Computational Fluid Dynamics in the Pharmaceutical Industry
Available Guidance and Best Practices for Conducting Forced Degradation Studies

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Related Content
Pink-white and blue-white capsule pills with concept of precision medicine with nanotechnology, proteomics, and advanced artificial intelligence to enhance diagnostics and patient-specific solutions. | Image Credit: ©Artinun - stock.adobe.com
August 12th 2025

Personalized and Patient-Centric Administration of Oral Medicines

Cynthia A. Challener
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 12th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 12th 2025

FDA Grants Approval to Celltrion for Expanded Indication of Actemra Biosimilar to Treat CRS

Feliza Mirasol
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 12th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 12th 2025

Bora Pharmaceuticals to Expand Midwest Manufacturing Site

Susan Haigney
High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com
August 12th 2025

The Future of Pharma: Connected, Continuous, and Compliant

Mike Hennessy Jr.